Stroke · 1995 · 35 citations · 29 references
Life SciencesNeurobiologyNeuroscienceImmunopathologyNeurochemistryNeurodegenerationImmunohistochemistryNeurodegenerative DiseasesNeurodegenerative DisordersTau PathologyIschemic NecrosisIschemic Neuronal Death
BACKGROUND AND PURPOSE: Tau-like immunoreactivity is known to develop in neurons under some experimental conditions simulating ischemia. The purpose of this study is to investigate the expression of tau-like immunoreactivity in the human brain after ischemic insult. METHODS: A series of autopsied human brains with or without ischemic lesion were investigated with immunohistochemistry (Alz-50, anti-tau, and anti-ubiquitin) and with silver-staining methods (Gallyas and Bodian methods). RESULTS: Punctate immunoreactivity to Alz-50 was visualized in the cytoplasm not only of the neurons in and around the ischemic lesion but also of the neurons free from classic ischemic changes around the necrosis. Some of the neurons around the ischemic lesion were stained by the Gallyas method. Immunostaining with anti-tau and anti-ubiquitin antibodies and the conventional Bodian method failed to visualize these neurons. CONCLUSIONS: The widespread appearance of Alz-50 immunoreactive neurons during the ischemic process signifies that tau-related proteins may be related to ischemic necrosis, but the lack of neurofibrillary tangles morphologically distinguishes ischemic development of tau-related proteins from the neurofibrillary degeneration in Alzheimer's disease.
29
A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Virginia M.‐Y. Lee, Brian J. Balin, László Ötvös et al. · Science · 1991 · 1.4K citations
A Neuronal Antigen in the Brains of Alzheimer Patients
Benjamin Wolozin, Alex Pruchnicki, Dennis W. Dickson et al. · Science · 1986 · 584 citations